Global Acupuncture MarketAccording to research by
Spherical Insights, the global acupuncture needle market was valued at $240 million in 2022 and is expected to grow to $596 million by 2032, with a compound annual growth rate (CAGR) of 9.5%.
The Chinese market, which annually produces and consumes about 1 billion acupuncture needles, is particularly promising.
Why is it a profitable investment?- Low production cost: The cost of producing one NANOKAN needle is approximately $0.05, while the cost of packaging 100 needles is $5.30.
- High profitability: Potential sales prices for a pack of 100 needles are:
- China – around 100 yuan (~$14.00)
- USA and EU – around $55
- High profit potential: Capturing just 10% of the Chinese market would allow us to sell about 1 million packs per year, generating around $10 million in annual profit.
Expected ReturnsThe realistic and attractive return on investment is approximately 20% per annum.
By investing in NANOKAN, you become part of a project with high scalability potential, consistent demand, and significant social impact, providing a reliable guarantee of successful returns on your investment.
Patent and Trademark ProtectionThe NANOKAN technology and product are protected by international patents and registered trademarks. As of today:
- Patents have been obtained for the method of applying the magnetic-separation nanofilm Fe₃O₄ using Atomic Layer Deposition (ALD).
- The NANOKAN trademark has been registered in Russia and China, and the registration process is ongoing in the USA, the United Kingdom, the EU, and other countries.
We value transparency and legal security for our investors, so all rights to the invention and its commercial use are protected at the international level.